This article reviews the risks associated with hyperglycemia in hospitalized patients, the biologic rationale for using insulin to prevent increases in glucose levels, and strategies for managing hyperglycemia in the hospital setting.
67th American Diabetes Association Annual Scientific Session Updates
This supplement will strive to educate physicians and diabetes educators as to the importance of avoiding hyperglycemia in hospitalized patients as well as the role of postprandial hyperglycemia in increasing the risk of cardiovascular disease.
Optimizing Your Approach to Insulin Therapy
This Insulin supplement presents the current state of knowledge in the management of type 2 diabetes and discusses practical approaches to initiating and maintaining an effective insulin regimen.
Incorporating Postprandial and Fasting Plasma Glucose into Clinical Management Strategies
Targeting plasma glucose is a widely accepted practice in the treatment of both type 1 and type 2 diabetes mellitus (DM).
Advances in Cardiometabolic Health
Assessing the cardiometabolic health of individuals involves the identification of cardiometabolic risk factors based on information relating to cholesterol, blood pressure, smoking, blood glucose, overweight/obesity, physical inactivity, and family history.
Insulin Therapy in Type 2 Diabetes
As the prevalence of diabetes continues to increase in the United States and around the world, increasing awareness of the role of insulin therapy as a key component in the care of individuals with type 2 diabetes is warranted.
Management and Prevention of Glucose Dysregulation
We have made tremendous progress in the last 2 decades to overcome smoking and other traditional risk factors for heart disease in the United States; however, we are now challenged by 2 new epidemics-obesity and type 2 diabetes.
Highlights of the Insulin Congress: The Evolving Science
The Insulin Congress, the first educational congress devoted to the evolving science and practice of insulin therapy, was held November 10-12, 2006 in Washington, DC. The meeting provided a forum for the discussion of state-of-the-art treatment of patients with diabetes, as well as an opportunity to evaluate the clinical relevance of recent research.
